Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Recommendation of “Moderate Buy” from Brokerages
Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the five analysts that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average […]
More Stories
Hemostemix (CVE:HEM) Trading Up 23.1% – Still a Buy?
Hemostemix Inc. (CVE:HEM – Get Free Report)’s share price was up 23.1% during trading on Thursday . The company traded...
iShares S&P 500 Growth ETF (NYSEARCA:IVW) Stock Holdings Reduced by Commonwealth Equity Services LLC
Commonwealth Equity Services LLC cut its position in shares of iShares S&P 500 Growth ETF (NYSEARCA:IVW – Free Report) by...
Synergia Energy (LON:SYN) Shares Down 6% – Here’s Why
Synergia Energy Ltd (LON:SYN – Get Free Report)’s stock price traded down 6% on Thursday . The stock traded as...
YASKAWA Electric (OTCMKTS:YASKY) Sets New 12-Month Low – Here’s Why
YASKAWA Electric Co. (OTCMKTS:YASKY – Get Free Report)’s share price reached a new 52-week low on Thursday . The stock...
Commonwealth Equity Services LLC Has $229.92 Million Stake in Vanguard Short-Term Bond ETF (NYSEARCA:BSV)
Commonwealth Equity Services LLC increased its stake in Vanguard Short-Term Bond ETF (NYSEARCA:BSV – Free Report) by 2.5% in the...
Commonwealth Equity Services LLC Cuts Stake in iShares Russell 1000 Value ETF (NYSEARCA:IWD)
Commonwealth Equity Services LLC decreased its holdings in iShares Russell 1000 Value ETF (NYSEARCA:IWD – Free Report) by 2.8% in...